Acute granulomatous interstitial nephritis in a patient with metastatic melanoma on targeted therapy with dabrafenib and trametinib—A case report

BACKGROUND: Combination molecular targeted therapy with dabrafenib plus trametinib has been shown to improve progression‐free survival and overall survival in patients with BRAF V600 mutated unresectable or metastatic melanoma. In general, these agents are well tolerated. Kidney related adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales: Krelle, Anna, Mathai, Vinod Kalapurackal, Kirkland, Geoff, Nott, Louise, Jose, Matthew D., Whale, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327652/
https://www.ncbi.nlm.nih.gov/pubmed/34350734
http://dx.doi.org/10.1002/cnr2.1520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327652/
https://www.ncbi.nlm.nih.gov/pubmed/34350734
http://dx.doi.org/10.1002/cnr2.1520

Ejemplares similares